2025
SJR Q1
JCR Q1 · 4,2
SCIE
Dergi ayrıntısı
Infectious Disease Clinics of North America
- Yayıncı
- W.B. Saunders
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
0891552015579824
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,482
- Quartile Q1
- H-Index 129
- Atıf/yayın 3,86
- Doküman (3y) 167
- Atıf (3y) 663
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,2
- 5Y JIF 5,9
- JCI 1,06
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Infectious Diseases Q1
- Microbiology (medical) Q1
Alanlar
- Medicine
WoS kategorileri
- Immunology | Infectious Diseases
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,482 | 4,2 | 5,9 | 1,06 | Q1 | 129 |
| 2024 | Q1 | Q1 | 1,796 | 4,1 | 6,4 | 1,37 | Q1 | 122 |
| 2023 | Q1 | Q1 | 1,36 | 6,1 | 6,3 | 0,91 | Q2 | 122 |
| 2022 | Q1 | Q2 | 1,453 | 4,4 | 6,1 | 1,21 | Q1 | 122 |
| 2021 | Q1 | Q2 | 1,395 | 5,9 | 7,1 | 1,1 | Q1 | 122 |
| 2020 | Q1 | Q1 | 1,854 | 6 | 7,4 | 1,42 | Q1 | 122 |
| 2019 | Q1 | Q2 | 1,584 | 3,7 | 5,4 | 1,29 | Q1 | 122 |
| 2018 | — | Q1 | — | 4,8 | 4,8 | 1,47 | Q1 | — |
| 2017 | Q1 | Q1 | 2,359 | 5,4 | 4,2 | 1,59 | Q1 | 122 |
| 2016 | Q1 | Q1 | 2,049 | 4,8 | 3,3 | — | — | 122 |
| 2015 | Q1 | Q2 | 1,438 | 2,8 | 2,7 | — | — | 122 |
| 2014 | Q2 | Q2 | 1,149 | 2,7 | 2,6 | — | — | 122 |
| 2013 | Q2 | Q3 | 1,112 | 2,3 | 2,8 | — | — | 122 |
| 2012 | Q1 | Q2 | 1,157 | 2,6 | 2,8 | — | — | 122 |
| 2011 | Q1 | Q2 | 1,249 | 3 | 3 | — | — | 122 |
| 2010 | Q2 | Q2 | 1,001 | 3 | 2,7 | — | — | 122 |
| 2009 | — | Q3 | — | 2,3 | 2,3 | — | — | — |
| 2008 | — | Q3 | — | 2,1 | 2,6 | — | — | — |
| 2007 | — | Q3 | — | 1,9 | 2,5 | — | — | — |
| 2006 | — | Q4 | — | 1,6 | — | — | — | — |
| 2005 | — | Q3 | — | 2,2 | — | — | — | — |
| 2004 | — | Q2 | — | 3,1 | — | — | — | — |
| 2003 | — | Q2 | — | 2 | — | — | — | — |
| 2002 | — | Q2 | — | 1,8 | — | — | — | — |
| 2001 | — | Q2 | — | 2,5 | — | — | — | — |
| 2000 | — | Q2 | — | 2,6 | — | — | — | — |
| 1999 | — | Q1 | — | 2,9 | — | — | — | — |
| 1998 | — | Q2 | — | 1,8 | — | — | — | — |
| 1997 | — | Q3 | — | 1,1 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q2 | Q1 | 66/183 |
| 2025 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 33/141 |
| 2024 | IMMUNOLOGY | SCIE | Q2 | Q1 | 63/183 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 26/137 |
| 2023 | IMMUNOLOGY | SCIE | Q1 | Q2 | 36/181 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q1 | Q2 | 12/132 |
| 2022 | IMMUNOLOGY | SCIE | Q2 | Q1 | 77/161 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q2 | Q1 | 40/96 |
| 2021 | IMMUNOLOGY | SCIE | Q2 | Q1 | 55/162 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q2 | Q1 | 29/95 |
| 2020 | IMMUNOLOGY | SCIE | Q2 | Q1 | 44/162 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 11/93 |
| 2019 | IMMUNOLOGY | SCIE | Q2 | Q1 | 71/159 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q2 | Q1 | 29/92 |
| 2018 | IMMUNOLOGY | SCIE | Q2 | Q1 | 40/158 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 14/89 |
| 2017 | IMMUNOLOGY | SCIE | Q1 | Q1 | 32/155 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 6/88 |
| 2016 | IMMUNOLOGY | SCIE | Q1 | — | 35/151 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q1 | — | 11/84 |
| 2015 | IMMUNOLOGY | SCIE | Q3 | — | 78/151 |
| 2015 | INFECTIOUS DISEASES | SCIE | Q2 | — | 30/83 |
| 2014 | IMMUNOLOGY | SCIE | Q2 | — | 74/148 |
| 2014 | INFECTIOUS DISEASES | SCIE | Q2 | — | 33/78 |
| 2013 | IMMUNOLOGY | SCIE | Q3 | — | 96/144 |
| 2013 | INFECTIOUS DISEASES | SCIE | Q3 | — | 46/72 |
| 2012 | IMMUNOLOGY | SCIE | Q3 | — | 82/137 |
| 2012 | INFECTIOUS DISEASES | SCIE | Q2 | — | 33/70 |
| 2011 | IMMUNOLOGY | SCIE | Q2 | — | 66/139 |
| 2011 | INFECTIOUS DISEASES | SCIE | Q2 | — | 27/70 |
| 2010 | IMMUNOLOGY | SCIE | Q2 | — | 60/134 |
| 2010 | INFECTIOUS DISEASES | SCIE | Q2 | — | 25/58 |
| 2009 | IMMUNOLOGY | SCIE | Q3 | — | 85/128 |
| 2009 | INFECTIOUS DISEASES | SCIE | Q3 | — | 33/57 |
| 2008 | IMMUNOLOGY | SCIE | Q3 | — | 83/121 |
| 2008 | INFECTIOUS DISEASES | SCIE | Q3 | — | 36/51 |
| 2007 | IMMUNOLOGY | SCIE | Q3 | — | 84/119 |
| 2007 | INFECTIOUS DISEASES | SCIE | Q3 | — | 34/50 |
| 2006 | IMMUNOLOGY | SCIE | Q4 | — | 91/117 |
| 2006 | INFECTIOUS DISEASES | SCIE | Q4 | — | 39/47 |
| 2005 | IMMUNOLOGY | SCIE | Q3 | — | 59/115 |
| 2005 | INFECTIOUS DISEASES | SCIE | Q3 | — | 24/43 |
| 2004 | IMMUNOLOGY | SCIE | Q2 | — | 32/111 |
| 2004 | INFECTIOUS DISEASES | SCIE | Q2 | — | 11/41 |
| 2003 | IMMUNOLOGY | SCIE | Q3 | — | 60/114 |
| 2003 | INFECTIOUS DISEASES | SCIE | Q2 | — | 18/41 |
| 2002 | IMMUNOLOGY | SCIE | Q3 | — | 67/119 |
| 2002 | INFECTIOUS DISEASES | SCIE | Q2 | — | 18/38 |
| 2001 | IMMUNOLOGY | SCIE | Q2 | — | 42/114 |
| 2001 | INFECTIOUS DISEASES | SCIE | Q2 | — | 13/37 |
| 2000 | IMMUNOLOGY | SCIE | Q2 | — | 33/116 |
| 2000 | INFECTIOUS DISEASES | SCIE | Q2 | — | 12/36 |
| 1999 | IMMUNOLOGY | SCIE | Q1 | — | 22/115 |
| 1999 | INFECTIOUS DISEASES | SCIE | Q1 | — | 8/35 |
| 1998 | IMMUNOLOGY | SCIE | Q2 | — | 54/120 |
| 1998 | INFECTIOUS DISEASES | SCIE | Q3 | — | 19/36 |
| 1997 | IMMUNOLOGY | SCIE | Q3 | — | 77/117 |
| 1997 | INFECTIOUS DISEASES | SCIE | Q3 | — | 22/34 |